Global Malaria Treatment Market Size, Status and Forecast 2024-2034
Global Malaria Treatment Scope and Market Size
Malaria Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Malaria Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Quinine
Chloroquine
Proguanil
Mefloquine
Pyrimethamine
Other
Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Advanz Pharmaceutical
Ipca Laboratories Ltd
Zydus Cadila
Glenmark
Olympus Corporation
Abbott
Sanofi
GlaxoSmithKline plc.
Novartis AG
TEVA PHARMACEUTICAL INDUSTRIES LTD
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malaria Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Quinine
1.2.3 Chloroquine
1.2.4 Proguanil
1.2.5 Mefloquine
1.2.6 Pyrimethamine
1.2.7 Other
1.3 Market by Application
1.3.1 Global Malaria Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E-Commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Malaria Treatment Market Perspective (2016-2027)
2.2 Malaria Treatment Growth Trends by Regions
2.2.1 Malaria Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Malaria Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Malaria Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Malaria Treatment Industry Dynamic
2.3.1 Malaria Treatment Market Trends
2.3.2 Malaria Treatment Market Drivers
2.3.3 Malaria Treatment Market Challenges
2.3.4 Malaria Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Malaria Treatment Players by Revenue
3.1.1 Global Top Malaria Treatment Players by Revenue (2016-2021)
3.1.2 Global Malaria Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Malaria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Malaria Treatment Revenue
3.4 Global Malaria Treatment Market Concentration Ratio
3.4.1 Global Malaria Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malaria Treatment Revenue in 2020
3.5 Malaria Treatment Key Players Head office and Area Served
3.6 Key Players Malaria Treatment Product Solution and Service
3.7 Date of Enter into Malaria Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Malaria Treatment Breakdown Data by Type
4.1 Global Malaria Treatment Historic Market Size by Type (2016-2021)
4.2 Global Malaria Treatment Forecasted Market Size by Type (2022-2027)
5 Malaria Treatment Breakdown Data by Application
5.1 Global Malaria Treatment Historic Market Size by Application (2016-2021)
5.2 Global Malaria Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Malaria Treatment Market Size (2016-2027)
6.2 North America Malaria Treatment Market Size by Type
6.2.1 North America Malaria Treatment Market Size by Type (2016-2021)
6.2.2 North America Malaria Treatment Market Size by Type (2022-2027)
6.2.3 North America Malaria Treatment Market Size by Type (2016-2027)
6.3 North America Malaria Treatment Market Size by Application
6.3.1 North America Malaria Treatment Market Size by Application (2016-2021)
6.3.2 North America Malaria Treatment Market Size by Application (2022-2027)
6.3.3 North America Malaria Treatment Market Size by Application (2016-2027)
6.4 North America Malaria Treatment Market Size by Country
6.4.1 North America Malaria Treatment Market Size by Country (2016-2021)
6.4.2 North America Malaria Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Malaria Treatment Market Size (2016-2027)
7.2 Europe Malaria Treatment Market Size by Type
7.2.1 Europe Malaria Treatment Market Size by Type (2016-2021)
7.2.2 Europe Malaria Treatment Market Size by Type (2022-2027)
7.2.3 Europe Malaria Treatment Market Size by Type (2016-2027)
7.3 Europe Malaria Treatment Market Size by Application
7.3.1 Europe Malaria Treatment Market Size by Application (2016-2021)
7.3.2 Europe Malaria Treatment Market Size by Application (2022-2027)
7.3.3 Europe Malaria Treatment Market Size by Application (2016-2027)
7.4 Europe Malaria Treatment Market Size by Country
7.4.1 Europe Malaria Treatment Market Size by Country (2016-2021)
7.4.2 Europe Malaria Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Malaria Treatment Market Size (2016-2027)
8.2 Asia-Pacific Malaria Treatment Market Size by Type
8.2.1 Asia-Pacific Malaria Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Malaria Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Malaria Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Malaria Treatment Market Size by Application
8.3.1 Asia-Pacific Malaria Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Malaria Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Malaria Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Malaria Treatment Market Size by Region
8.4.1 Asia-Pacific Malaria Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Malaria Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Malaria Treatment Market Size (2016-2027)
9.2 Latin America Malaria Treatment Market Size by Type
9.2.1 Latin America Malaria Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Malaria Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Malaria Treatment Market Size by Type (2016-2027)
9.3 Latin America Malaria Treatment Market Size by Application
9.3.1 Latin America Malaria Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Malaria Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Malaria Treatment Market Size by Application (2016-2027)
9.4 Latin America Malaria Treatment Market Size by Country
9.4.1 Latin America Malaria Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Malaria Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Malaria Treatment Market Size (2016-2027)
10.2 Middle East & Africa Malaria Treatment Market Size by Type
10.2.1 Middle East & Africa Malaria Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Malaria Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Malaria Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Malaria Treatment Market Size by Application
10.3.1 Middle East & Africa Malaria Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Malaria Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Malaria Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Malaria Treatment Market Size by Country
10.4.1 Middle East & Africa Malaria Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Malaria Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Advanz Pharmaceutical
11.1.1 Advanz Pharmaceutical Company Details
11.1.2 Advanz Pharmaceutical Business Overview
11.1.3 Advanz Pharmaceutical Malaria Treatment Introduction
11.1.4 Advanz Pharmaceutical Revenue in Malaria Treatment Business (2016-2021)
11.1.5 Advanz Pharmaceutical Recent Development
11.2 Ipca Laboratories Ltd
11.2.1 Ipca Laboratories Ltd Company Details
11.2.2 Ipca Laboratories Ltd Business Overview
11.2.3 Ipca Laboratories Ltd Malaria Treatment Introduction
11.2.4 Ipca Laboratories Ltd Revenue in Malaria Treatment Business (2016-2021)
11.2.5 Ipca Laboratories Ltd Recent Development
11.3 Zydus Cadila
11.3.1 Zydus Cadila Company Details
11.3.2 Zydus Cadila Business Overview
11.3.3 Zydus Cadila Malaria Treatment Introduction
11.3.4 Zydus Cadila Revenue in Malaria Treatment Business (2016-2021)
11.3.5 Zydus Cadila Recent Development
11.4 Glenmark
11.4.1 Glenmark Company Details
11.4.2 Glenmark Business Overview
11.4.3 Glenmark Malaria Treatment Introduction
11.4.4 Glenmark Revenue in Malaria Treatment Business (2016-2021)
11.4.5 Glenmark Recent Development
11.5 Olympus Corporation
11.5.1 Olympus Corporation Company Details
11.5.2 Olympus Corporation Business Overview
11.5.3 Olympus Corporation Malaria Treatment Introduction
11.5.4 Olympus Corporation Revenue in Malaria Treatment Business (2016-2021)
11.5.5 Olympus Corporation Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Malaria Treatment Introduction
11.6.4 Abbott Revenue in Malaria Treatment Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Malaria Treatment Introduction
11.7.4 Sanofi Revenue in Malaria Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Details
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Malaria Treatment Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Malaria Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Malaria Treatment Introduction
11.9.4 Novartis AG Revenue in Malaria Treatment Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 TEVA PHARMACEUTICAL INDUSTRIES LTD
11.10.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Details
11.10.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Business Overview
11.10.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Malaria Treatment Introduction
11.10.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Revenue in Malaria Treatment Business (2016-2021)
11.10.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details